Veterinary Chemistry Analyzers Market
                     Veterinary Chemistry Analyzers Market
A veterinary chemistry analyzer (VCA) is used for in-house veterinary use. These 
analyzers are used to determine the concentration of certain metabolites, 
proteins, electrolytes or drugs in samples of urine, plasma, serum, cerebrospinal 
fluid and/or other body fluids of animals. In other words, VCA is a blood and 
urine testing instrument that analyzes around 12 biochemical tests 
simultaneously, by using the samples of either urine, serum or plasma in around 
6 minutes. The types of analyzers include, urine analyzers, blood gas & 
electrolyte analyzers, glucometers, and others, which are used by hospitals, 
medical labs, and for home use. There are several types of tests such as 
hematology test that includes the cell counter for blood counts, immunoassays 
for detecting antibodies, and tests for ions that measure voltage differences and 
others.
Veterinary Chemistry Analyzers Market - Drivers
Increasing animal population, growing pet adoption, increasing demand for pet 
insurance, along with high animal health expenditure and increase in number of 
veterinary practitioners are the factors driving growth of the veterinary 
chemistry analyzers market. According to the data published by American Pet 
Product Association (APPA) in 2018, total pet healthcare expenditure in America 
in 2017 was US$ 69.51 billion, which reached to US$ 72.13 billion in 2018.
Get the 
sample:-https://www.coherentmarketinsights.com/insight/request-sample/267
7
Increasing prevalence of zoonotic diseases is further contributing towards 
growth of the veterinary chemistry analyzers market. According to the Centers 
for Disease Control and Prevention (CDC) in 2017, 3 out of 4 emerging infectious 
diseases in people are transmitted through animals. E.coli infection, 
chickungunya, dengue, and malaria are some mild to severe zoonotic diseases. 
According to the World Health Organization, in 2015, around 212 million cases 
of malaria were recorded worldwide with 429,000 deaths. Therefore, increasing 
need for control measures for zoonotic diseases is expected to boost the market 
growth. 
Key manufacturers in the market are focused on launching new veterinary 
chemistry analyzers, which is expected to boost the market growth. For 
instance, in November 2015, Diatron Group, global provider of hematology and 
clinical chemistry analyzers, launched a new 5-part differential veterinary 
hematology analyzer- the Abacus Vet5 in Dusseldorf at the Medica show. The 
Abacus Vet5 consists of new features with completely new look providing 
improved communication with laboratory information systems (LIS). Moreover, 
in April 2015, Horiba UK became USHIO’S official distributor for Amishield 
veterinary chemical chemistry analyzer. In 2015, Horiba UK launched the 
product Amishield veterinary chemical chemistry analyzer officially at BSAVA 
tradeshow in Birmingham, U.K. This product is capable of performing 
biochemistry, electrolytes, and immunoassay diagnostics in the veterinary field.
However, high cost associated with veterinary chemistry analyzers is expected 
to restrain growth of the veterinary chemistry analyzers market.
Get PDF 
link:-https://www.coherentmarketinsights.com/insight/request-pdf/2677
On the basis of region, the global veterinary chemistry analyzers market is 
segmented into North America, Latin America, Europe, Asia Pacific, Middle East, 
and Africa. North America holds dominant position in the global veterinary 
chemistry analyzers market. This is owing to increasing animal health 
expenditure and high demand for animal-derived food in the region. According 
to American Pet Products Association, the total pet industry expenditure which 
includes the food, supplies and over the counter medicine, in 2017 was US$ 69.4 
billion.
Key market players in the region are focused on adopting acquisition strategies 
to expand their geographical presence. For instance, in May 2018, Zoetis Inc. 
and Abaxis Inc. announced the definite merger agreement in which Zoetis Inc. 
will acquire Abaxis Inc. This acquisition is expected to improve Zoetis Inc.’s 
presence in the veterinary diagnostics sector.
Asia Pacific is projected to be the fastest growing market over the forecast 
period, owing to the high incidence of vitamin deficiency, bacterial infection, 
gout in dogs and increase in awareness of various health issues.
Veterinary Chemistry Analyzers Market - Competitive Landscape
Some of the key players operating in the global veterinary chemistry analyzers 
market include, Abaxis Inc., IDEXX Laboratories Inc., Heska Corporation, DiaSys 
Diagnostics Systems, Derechos reservados Diconex, URIT Medical, Randox 
Laboratories Ltd., Eurolyser Diagnostica GmbH, ARKRAY Inc., and Alfa 
Wassermann Inc.
Key Development
In 2017, Boule Diagnostics, launched Exigo C200, a fully automated chemistry 
analyzer for animal health.
In 2015, Diatron, a global provider of hematology and clinical chemistry 
analyzer, launched Abacus Vet5, a veterinary hematology analyzer.
In 2015, Horiba Medical Inc., launched AmiShield veterinary clinical chemical 
analyzer.
In 2014, IDEXX Laboratories Inc., introduced catalyst one chemistry analyzer for 
animal health diagnosis.
In 2012, Heska Corporartion, a leading provider of veterinary diagnostic and 
specialty products has launched Element DC veterinary chemistry analyzer.
Veterinary Chemistry Analyzers Market - Market Taxonomy
Get more 
info:-https://www.coherentmarketinsights.com/ongoing-insight/veterinary-che
mistry-analyzers-market-2677
Mr. Raj Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Website: https://www.coherentmarketinsights.com
Visit Our Blog: http://bit.ly/snowy
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm 
offering action-ready syndicated research reports, custom market analysis, 
consulting services, and competitive analysis through various recommendations 
related to emerging market trends, technologies, and potential absolute dollar 
opportunity.